Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

uniQure NV (QURE)

uniQure NV
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:QURE
DateTimeSourceHeadlineSymbolCompany
10/12/202421:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QUREuniQure NV
10/12/202421:33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:QUREuniQure NV
10/12/202412:22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QUREuniQure NV
10/12/202412:05GlobeNewswire Inc.uniQure Announces Alignment with FDA on Key Elements of Accelerated Approval Pathway for AMT-130 in Huntington’s DiseaseNASDAQ:QUREuniQure NV
21/11/202414:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QUREuniQure NV
21/11/202412:05GlobeNewswire Inc.uniQure Announces Dosing of First Patient in GenTLE Phase I/IIa Clinical Trial of AMT-260 for the Treatment of Refractory Mesial Temporal Lobe EpilepsyNASDAQ:QUREuniQure NV
14/11/202417:01Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:QUREuniQure NV
05/11/202414:08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:QUREuniQure NV
05/11/202413:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QUREuniQure NV
05/11/202412:05GlobeNewswire Inc.uniQure Announces Third Quarter 2024 Financial Results and Highlights Recent Company ProgressNASDAQ:QUREuniQure NV
26/10/202401:48Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:QUREuniQure NV
26/10/202401:48Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:QUREuniQure NV
15/10/202411:49Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QUREuniQure NV
15/10/202411:05GlobeNewswire Inc.uniQure Announces Dosing of First Patient in Phase I/II Clinical Trial of AMT-162 for the Treatment SOD1-ALSNASDAQ:QUREuniQure NV
23/09/202411:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QUREuniQure NV
23/09/202411:05GlobeNewswire Inc.uniQure Announces Orphan Drug Designation Granted to AMT-191 for the Treatment of Fabry DiseaseNASDAQ:QUREuniQure NV
15/08/202411:48Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QUREuniQure NV
15/08/202411:05GlobeNewswire Inc.uniQure Announces Dosing of First Patient in Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry DiseaseNASDAQ:QUREuniQure NV
01/08/202412:54Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:QUREuniQure NV
01/08/202411:51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QUREuniQure NV
01/08/202411:43Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:QUREuniQure NV
01/08/202411:05GlobeNewswire Inc.uniQure Announces Second Quarter 2024 Financial Results and Provides Company UpdateNASDAQ:QUREuniQure NV
23/07/202411:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QUREuniQure NV
23/07/202411:05GlobeNewswire Inc.uniQure Announces Closing of Sale of Manufacturing Facility to GenezenNASDAQ:QUREuniQure NV
09/07/202411:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QUREuniQure NV
09/07/202411:05GlobeNewswire Inc.uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s DiseaseNASDAQ:QUREuniQure NV
01/07/202411:05PR Newswire (US)Genezen to Acquire uniQure's Commercial Gene Therapy Manufacturing Operations in Lexington, MANASDAQ:QUREuniQure NV
01/07/202411:05GlobeNewswire Inc.uniQure Announces Sale of Commercial Manufacturing Facility to GenezenNASDAQ:QUREuniQure NV
20/06/202412:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QUREuniQure NV
20/06/202412:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QUREuniQure NV
 Showing the most relevant articles for your search:NASDAQ:QURE